Home » Topics » Regulatory » Patents

Patents
RSS

Novira Therapeutics describes agents for HBV infection

Oct. 6, 2016

Almirall patents Nav1.7 channel blockers for pain

Oct. 6, 2016

Toray Industries prepares and tests agents for urinary incontinence

Oct. 6, 2016

Helmholtz-Zentrum fur Infektionsforschung develops lecB inhibitors

Oct. 6, 2016

Wuhan LL Science and Technology Development announces nitric oxid donors

Oct. 6, 2016

Sumitomo Dainippon Pharma develops PDE1 inhibitors

Oct. 6, 2016

The Vanderbilt University reports mGlu2 receptor negative allosteric modulators

Oct. 5, 2016

GlaxoSmithKline presents bromodomain inhibitors

Oct. 5, 2016

Bristol-Myers Squibb describes TNF-alpha antagonists

Oct. 5, 2016

Heptares Therapeutics discloses muscarinic M1 and M4 receptor agonists

Oct. 5, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...